UPDATE 1-Merck leaps into COVID-19 development fray with vaccine, drug deals
May 26, 2020 at 07:24 AM EDT
Merck & Co Inc, which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.